Jefferies assumed / downgraded Myriad Genetics (NASDAQ: MYGN) from Buy to Hold with a price target of $31.00.

Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE